Promising New Drug for Hepatitis C Infection

Anthony L. Komaroff

NEJM Journal Watch（2010）

引用 0|浏览6

暂无评分

摘要

Pegylated interferon-α plus ribavirin is the current antiviral regimen used for hepatitis C virus (HCV) infection. However, some patients (especially

查看译文

关键词

new drug

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要